Jennifer Lynn Minai-azary - Net Worth and Insider Trading
Jennifer Lynn Minai-azary Net Worth
The estimated net worth of Jennifer Lynn Minai-azary is at least $88,600 dollars as of 2024-11-07. Jennifer Lynn Minai-azary is the CFO of Context Therapeutics Inc and owns about 40,000 shares of Context Therapeutics Inc (CNTX) stock worth over $88,600. Details can be seen in Jennifer Lynn Minai-azary's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jennifer Lynn Minai-azary has not made any transactions after 2022-12-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jennifer Lynn Minai-azary
Jennifer Lynn Minai-azary Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jennifer Lynn Minai-azary owns 2 companies in total, including Tempest Therapeutics Inc (TPST) , and Context Therapeutics Inc (CNTX) .
Click here to see the complete history of Jennifer Lynn Minai-azary’s form 4 insider trades.
Insider Ownership Summary of Jennifer Lynn Minai-azary
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TPST | Tempest Therapeutics Inc | 2021-02-01 | Chief Financial Officer |
| CNTX | Context Therapeutics Inc | 2022-12-16 | Chief Financial Officer |
Jennifer Lynn Minai-azary Latest Holdings Summary
Jennifer Lynn Minai-azary currently owns a total of 1 stock. Jennifer Lynn Minai-azary owns 40,000 shares of Context Therapeutics Inc (CNTX) as of December 16, 2022, with a value of $88,600.
Latest Holdings of Jennifer Lynn Minai-azary
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CNTX | Context Therapeutics Inc | 2022-12-16 | 40,000 | 2.22 | 88,600 |
Holding Weightings of Jennifer Lynn Minai-azary
Jennifer Lynn Minai-azary Form 4 Trading Tracker
According to the SEC Form 4 filings, Jennifer Lynn Minai-azary has made a total of 2 transactions in Context Therapeutics Inc (CNTX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Context Therapeutics Inc is the acquisition of 25,000 shares on December 16, 2022, which cost Jennifer Lynn Minai-azary around $18,500.
Insider Trading History of Jennifer Lynn Minai-azary
- 1
Jennifer Lynn Minai-azary Trading Performance
GuruFocus tracks the stock performance after each of Jennifer Lynn Minai-azary's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jennifer Lynn Minai-azary is -21.86%. GuruFocus also compares Jennifer Lynn Minai-azary's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jennifer Lynn Minai-azary within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jennifer Lynn Minai-azary's insider trading performs compared to the benchmark.
Performance of Jennifer Lynn Minai-azary
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -10.18 | | | | | |
| Relative Return to S&P 500(%) | -7.39 | | | | | |
Jennifer Lynn Minai-azary Ownership Network
Ownership Network List of Jennifer Lynn Minai-azary
Ownership Network Relation of Jennifer Lynn Minai-azary
Jennifer Lynn Minai-azary Owned Company Details
What does Tempest Therapeutics Inc do?
Who are the key executives at Tempest Therapeutics Inc?
Jennifer Lynn Minai-azary is the Chief Financial Officer of Tempest Therapeutics Inc. Other key executives at Tempest Therapeutics Inc include 10 percent owner Versant Venture Capital Vi, L.p. , director & Chief Executive Officer Stephen R Brady , and Chief Medical Officer Samuel Whiting .
Tempest Therapeutics Inc (TPST) Insider Trades Summary
Over the past 18 months, Jennifer Lynn Minai-azary made no insider transaction in Tempest Therapeutics Inc (TPST). Other recent insider transactions involving Tempest Therapeutics Inc (TPST) include a net sale of 787,999 shares made by Versant Venture Capital Vi, L.p. , a net purchase of 35,000 shares made by Stephen R Brady , and a net purchase of 4,672 shares made by Samuel Whiting .
In summary, during the past 3 months, insiders sold 787,999 shares of Tempest Therapeutics Inc (TPST) in total and bought 0 shares, with a net sale of 787,999 shares. During the past 18 months, 787,999 shares of Tempest Therapeutics Inc (TPST) were sold and 39,672 shares were bought by its insiders, resulting in a net sale of 748,327 shares.
Tempest Therapeutics Inc (TPST)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tempest Therapeutics Inc Insider Transactions
Jennifer Lynn Minai-azary Mailing Address
Above is the net worth, insider trading, and ownership report for Jennifer Lynn Minai-azary. You might contact Jennifer Lynn Minai-azary via mailing address: 110 Miller Avenue, Suite 100, Ann Arbor Mi 48104.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
